Patents by Inventor Mathieu Sertorio

Mathieu Sertorio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FIBROSIS SUSCEPTIBILITY IL22RA2 GENE AND USES THEREOF
    Publication number: 20190323060
    Abstract: The present invention discloses the identification of a fibrosis susceptibility gene locus, the IL22RA2 gene locus, which can be used for detecting predisposition to, diagnosis and prognosis of fibrosis as well as for the screening of therapeutically active drugs. The invention further provides a method for determining the likelyhood of a patient affected with a viral infection to respond to a treatment with an antiviral agent and/or an interferon, which method comprises determining alteration in IL22RA2 gene locus or in TL22RA2 expression or IL22RA2 protein activity in a biological sample of the patient.
    Type: Application
    Filed: October 18, 2018
    Publication date: October 24, 2019
    Inventors: Alain Dessein, Mathieu Sertorio, Laurent Argiro
  • Fibrosis susceptibility IL22RA2 gene and uses thereof
    Patent number: 10150989
    Abstract: The present invention discloses the identification of a fibrosis susceptibility gene locus, the IL22RA2 gene locus, which can be used for detecting predisposition to, diagnosis and prognosis of fibrosis as well as for the screening of therapeutically active drugs. The invention further provides a method for determining the likelihood of a patient affected with a viral infection to respond to a treatment with an antiviral agent and/or an interferon, which method comprises determining alteration in IL22RA2 gene locus or in IL22RA2 expression or IL22RA2 protein activity in a biological sample of the patient.
    Type: Grant
    Filed: August 3, 2012
    Date of Patent: December 11, 2018
    Assignees: UNIVERSITE D'AIX MARSEILLE, INSERM
    Inventors: Alain Dessein, Mathieu Sertorio, Laurent Argiro
  • FIBROSIS SUSCEPTIBILITY IL22RA2 GENE AND USES THEREOF
    Publication number: 20140295427
    Abstract: The present invention discloses the identification of a fibrosis susceptibility gene locus, the IL22RA2 gene locus, which can be used for detecting predisposition to, diagnosis and prognosis of fibrosis as well as for the screening of therapeutically active drugs. The invention further provides a method for determining the likelyhood of a patient affected with a viral infection to respond to a treatment with an antiviral agent and/or an interferon, which method comprises determining alteration in IL22RA2 gene locus or in IL22RA2 expression or IL22RA2 protein activity in a biological sample of the patient.
    Type: Application
    Filed: August 3, 2012
    Publication date: October 2, 2014
    Applicant: UNIVERSITE D'AIX-MARSEILLE
    Inventors: Alain Dessein, Mathieu Sertorio, Laurent Argiro